Search Results 21-30 of 17779 for Assay
A Study to Evaluate the Diagnostic Potential of a Lateral Flow Assay to Detect QSOX1 Peptide in Patients With or At Risk for Pancreatic Cancer.
The purpose of this study is to evaluate the clinical performance of the Aptima CMV Quant assay on the Panther system in ethylenediaminetetraacetic acid (EDTA) ...
The purpose of this study is to explore the clinical utility of routinely measuring thymidine kinase activity (TKa) in HR+ metastatic breast cancer patients ...
The purpose of this study is to validate an internally developed assay for the detection of BRAF V600E mutations in cfDNA from the peripheral blood of patients ...
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol · Overview · Participation eligibility · Participating Mayo Clinic ...
Methylated DNA markers (MDMs) assayed from plasma have been used to detect other cancers. Building on that knowledge, Mayo Clinic researchers recently conducted ...
To evaluate the ability of the plasma MDM assay to predict CRC recurrence when tested serially following curative resection of CRC metastases. Participation ...
A Study to Refine and Modify the Granulocyte Antibody Test to Provide Patients the Most Sensitive and Accurate Blood Serum Assay Available. ... assay and a ...
The purpose of this study is to evaluate the safety and effectiveness of the VERIS CMV Assay as an aid in the management of anti-CMV treatment for solid ...
... assay measures of aSyn, relative to normal control subjects. Specific Aim 2. In second biopsies of skin from subjects with DLB, PD and PDD, assess whether ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!